CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...